Banner 1140x138

List of posters

Posters will be displayed on digital screens in the Exhibition Hall 2, together with the Internet Corner.
  • P-01
    ALTERED EXPRESSION OF THE KISSPEPTIN/KISS1R AND NEUROKININ B/NK3R SYSTEMS IN MURAL GRANULOSA AND CUMULUS CELLS OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
    V. Blasco Rodríguez1, F. Pinto Pérez2, N. Prados Dodd1, L. Candenas De Luján2, M. Fernández Sánchez1.
    1IVIRMA Sevilla, Sevilla, Spain; 2Instituto de Investigaciones Químicas, CSIC, Sevilla, Spain.
  • P-02
    KIR-HLA-C MISMATCH AND NOT “IMMUNE REJECTION” EXPLAINS EMBRYO PLACENTATION FAILURE IN OOCYTE DONATION ART
    D. Alecsandru1, A. Pacheco1, N. Garrido2, A. Barrio1, A. Fabris1, P. Aparicio1, A. Pellicer3, J.A. Garcia-Velasco1.
    1IVIRMA, Madrid, Spain; 2IVI Foundation, Valencia, Spain; 3IVIRMA, Rome, Italy.
  • P-03
    PERCENTAGES OF ANEUPLOIDIES BY AGE GROUPS ARE SIMILAR IN THE SUB-FERTILE POPULATION AND IN SPONTANEOUS PREGNANCIES THAT ENDS INTO ABORTION.
    Y. Cabello1, A. Villa2, E. Carrillo2, D. Ordonez1.
    1Hospital Ruber Juan Bravo Quironsalud, Madrid, Spain; 2Hospital Ruber, Madrid, Spain.
  • P-04
    PARENTAL HLA-C ALLOTYPES ARE PREDICTIVE OF PREGNANCY LOSS AFTER SINGLE EUPLOID EMBRYO TRASNFERS IN PATIENTS WITH INHIBITORY KIR GENOTYPES
    D. Marin1, X. Tao2, L. Sun2, M. Yang2, Y. Zhan2, R. Scott1.
    1IVIRMA New Jersey, Basking Ridge, United States; 2Foundation for Embryonic Competence, Basking Ridge, United States.
  • P-05
    A HIGH RESOLUTION X CHROMOSOME COPY NUMBER VARIATION MAP IN FERTILE FEMALES AND WOMEN WITH PRIMARY OVARIAN INSUFFICIENCY
    S. Yatsenko1, M. Wood-Trageser2, T. Chu1, H. Jiang1, A. Rajkovic3.
    1Magee Womens Research Institute, University of Pittsburgh, United States; 2University of Pittsburgh, Pittsburgh, United States; 3University of California San Francisco, San Francisco, United States.
  • P-06
    ASSOCIATION BETWEEN TRANSCRIPTIONAL STUDY OF RECEPTIVITY AND IMMUNOLOGICAL FUNCTIONALITY OF ENDOMETRIUM
    G. Gutierrez1, D. Cotan2, A. Martinez Lara2, L. Barreiro3, E. Incera1, S. Mayol1, A. Pasqualini4, J. Horcajadas3.
    1Inmunogenesis-Conicet, Buenos Aires, Argentina; 2Pronacera Therapeutics, Sevilla, Spain; 3SINAE, Sevilla, Spain; 4Halitus, Buenos Aires, Argentina.
  • P-07
    MAPPING OF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) ALONG A HETEROZYGOSITY PLOT CORRELATES WITH DNA COPY NUMBER IN COMPREHENSIVE CHROMOSOME SCREENING (CCS)
    J. Kim1, C. Jalas2, B. Hanson1, A. Tiegs1, E. Osman1, S. Neal1, R. Scott, Jr.1.
    1IVIRMA of NJ, Basking Ridge, United States; 2FEC, Basking Ridge, United States.
  • P-08
    A CASE REPORT OF FETOPLACENTAL MOSAICISM DETECTED AFTER CONFIRMATION ANALYSIS OF A POSITIVE NON-INVASIVE PRENATAL TESTING (NIPT) RESULT.
    N. Galindo1, M. Munoz1, L. Rodrigo2, M. Milan2, V. Legidos1, M. Martinez-Beltran1, I. Perez-Cano1, C. Rubio2.
    1IVI, Alicante, Spain; 2IGENOMIX, Valencia, Spain.
  • P-09
    IS PARENTAL CONSANGUINITY ASSOCIATED WITH LOW OVARIAN RESERVE AND HIGHER RATE OF ANEUPLOIDIES?
    L. Melado1, A. Arnanz1, N. De Munck1, I. Elkhatib1, G. Mollá2, B. Lawrenz1, H. Mousavi Fatemi1.
    1IVI Middle East, Abu Dhabi, United Arab Emirates; 2UAGI IVI Foundation, Valencia, Spain.
  • P-10
    THE ROLE OF GNRH ANTAGONISTS IN INTRAUTERINE INSEMINATION: A 3-YEAR RETROSPECTIVE STUDY.
    A. Lera Ramírez1, L. Gil Guillén1, K.M. Pavón Sáenz1, D.C. Méndez Guevara1, A. Solé Mayoral1, A.M. Muñoz Ledesma1, P. Merino García1, J.M. Viteri Estévez1, A.C. Acha Salazar1, M. García Yuste1, A.B. Rodríguez Bújez1, E. Mancha Heredero1, Y. Pascual Arévalo1, C.F. Montoya García2, M.C. Redondo Llorente1.
    1Hospital Universitario Río Hortega, Valladolid, Spain; 2Hospital General Río Carrión, Palencia, Spain.
  • P-11
    HOW DOES THE NATIONAL LEGAL FRAMEWORK SUPPORT SURROGACY AS AN OPTION OF CROSS BORDER REPRODUCTIVE CARE IN THE EU? OUR EXPERIENCE IN GREECE
    I. Zervomanolakis, E. Nikolopoulou, A. Dimou, E. Nikitos, K. Agapitou, S. Kallergi, M. Botzaki, C. Makri, K. Diamantopoulou, D. Pappa, A. Spyrou, T. Mantzavinos.
    Institute of Life IASO, Marousi, Athens, Greece.
  • P-12
    ASSISTED REPRODUCTION TREATMENT IN A PATIENT WITH A HISTORY OF HYDATIDIFORM MOLE.
    L. Asensio Romero, M.J. García Rubio, M. Valiente Cortés, B. Martín Cabrejas, G. Serrano Olmedo, J.M. Moreno Cebeira, C. Martín Caballero.
    Hospital Universitario Fundación de Alcorcón, Alcorcón, Spain.
  • P-13
    DELTA FOLLITROPIN IN IVF CYCLE STIMULATION: A SERIES OF 59 CASES.
    J. Sanz Pablos, M. Hernandez Ontoria, L. Marqueta, M. Abad, M. Carrera, E. Escalante, N. Ruiz, L. De La Fuente.
    Hospital 12 Octubre, Madrid, Spain.
  • P-14
    EVALUATION OF THE EFFICIENCY OF CONTROLLED OVARIAN STIMULATION BY FORT IN PATIENTS CLASSIFIED ACCORDING TO POSEIDON GROUP CRITERIA WITH LOW RESERVE
    S. Vazquez Rodriguez1, R. Garrido Casserras1, J. Escrig Estrems1, N. Pellicer De Castellví1, M. Duarte Perez1, J.M. Soler Torró2, R. Taroncher Dasí1, N. Blasco Ramos1, J.M. Rubio Rubio1.
    1Human Reproduction Unit, Hospital La Fe Valencia, Spain; 2Health Direction Department, La Ribera Valencia, Spain.
  • P-15
    RETROSPECTIVE ANALYSIS AND OUTCOMES OF 891 INTRAUTERINE INSEMINATIONS CYCLES PERFORMED BETWEEN 2013 AND 2018 IN URUGUAY.
    C. Virginia1, M. Jose2, O. Rosina3.
    1Hospital de Clinicas. Clinica Ginecologica B. Facultad de Medicina. UdelaR. COSEM, Montevideo, Uruguay; 2Hospital Pereira Rossell, Montevideo, Uruguay; 3Fertilab. COSEM, Montevideo, Uruguay.
  • P-16
    GROWTH HORMONE CO-TREATMENT EVALUATION IN IN VITRO FERTILIZATION IN POOR RESPONDING PATIENTS USING GNRH ANTAGONISTA SHORT PROTOCOL
    J.F.D. Macedo1, M.R. Oliveira1, L.M.O. Gomes1, G.C.D. Macedo1, G.C.D. Macedo1, D.O. Gomes1, O.G. Martins1, L.A. Quirino1, B.O. Ambrogi1, S.I.S.D. Santos2.
    1Reproferty, São José dos Campos, Brazil; 2Fundação Universitária Vida Cristã, Pindamonhangaba, Brazil.
  • P-17
    ASSESSMENT OF DHEA SUPPLEMENTATION REGARDING THE OVARIAN RESPONSE OF POOR RESPONDING PATIENTS SUBMITTED TO THE OVARIAN HYPERESTIMULATION PROTOCOL
    J.F.D. Macedo1, M.R. Oliveira1, L.M.O. Gomes1, G.C.D. Macedo1, G.C.D. Macedo1, D.O. Gomes1, C.D.D.S. Francisquini1, B.O. Ambrogi1, L.A. Quirino1, S.I.S. Santos2.
    1Reproferty, São José dos Campos, Brazil; 2Fundação Vida Cristã, Pindamonhangaba, Brazil.
  • P-18
    PHYSICAL ACTIVITY OF INFERTILE WOMEN BEFORE, DURING AND AFTER IN VITRO FERTILIZATION TREATMENT AND ITS EFFECT ON PREGNANCY OUTCOME
    D. Sõritsa1, A. Salumets2, F.B. Ortega3, S. Altmäe4.
    1Elite Clinic, Tartu, Estonia; 2Competence Centre on Health Technologies, Tartu, Estonia; 3Department of Physical Education and Sports, Faculty of Sport Sciences, University of Granada, Granada, Spain; 4Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada, Spain.
  • P-19
    POOR OVARIAN RESPONSE IN POLYCYSTIC OVARY SYNDROME (PCOS) WITH LOW LEVEL OF ANTI MULLERIAN HORMONE (AMH) IN UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTRE
    M.A. Abu, M.F. Ahmad, A.K. Abdul Karim, M.H. Omar.
    UKM Medical Center, Kuala Lumpur, Malaysia.
  • P-20
    THE URINE LH TEST DURING FINAL OOCYTE MATURATION IN EGG DONATION PROGRAMME
    R. Streda, N. Mardesicova, L. Jelinkova, T. Mardesic.
    Sanatorium Pronatal, Praque, Czech Republic.
  • P-21
    VITAMIN D DEFICIENCY IN OOCYTE DONORS AND ICSI TREATMENT OUTCOME IN OOCYTE DONOR RECIPIENTS.
    N. Christoforidis, M. Dimitraki, C. Pappas, N. Anesidis, M. Kiriakidis, A. Karkanaki, K. Kalinderi, A. Chatziparasidou.
    Embryolab Fertility Centre, Thessaloniki, Greece.
  • P-22
    LIVE BIRTH RATES WITH ESTRADIOL PATCH AND GNRH-ANTAGONIST PROTOCOL IN VERY POOR PROGNOSIS PATIENTS WITH PREVIOUS IVF CYCLES WITHOUT OOCYTE DEVELOPMENT, FERTILIZATION AND/OR EMBRYO DEVELOPMENT
    Ö. Seçilmiş Kerimoğlu, S.A. Yılmaz, A.G. Kebapçılar.
    Selcuk University Medicine Faculty, IVF Center, Konya, Turkey.
  • P-23
    AN INITIAL EVALUATION OF THE EFFICACY AND SAFETY OF RECOMBINANT FOLLICLE STIMULATION HORMONE DELTA IN A UK FERTILITY CLINIC
    A. Fernández Ponce, D. Yell, A. Drakeley.
    Hewitt Fertility Centre, Liverpool Women’s NHS Foundation Trust, Liverpool, United Kingdom.
  • P-24
    WHEN IN VITRO FERTILIZATION FAILS: IS INTRAUTERINE INSEMINATION A REASONABLE TREATMENT STRATEGY?
    S. Neal, A. Tiegs, E. Osman, J. Kim, B. Hanson, M. Werner, R. Scott.
    IVI/RMA New Jersey, Basking Ridge, NJ, United States.
  • P-25
    THE EFFECT OF OVARIAN RESPONSE ON CLINICAL PREGNANCY AND DELIVERY RATES IN AN OOCYTE DONOR POPULATION
    B. Hanson, J. Kim, A. Tiegs, E. Osman, S. Neal, M. Werner, R. Scott.
    RMA New Jersey, Basking Ridge, NJ, United States.
  • P-26
    INFLUENCE OF THE NUMBER OF DONATIONS ON THE SUCCESS OF THE EGG DONATION PROGRAM
    C. Rodriguez Ruiz De Oña, E. Gil Arribas, R. Herrer Saura, P. Valero Sanchez, V. Ramirez Cabau, J. Serna Lopez.
    IVI Zaragoza, Zaragoza, Spain.
  • P-27
    SPONTANEOUS OVULATION VERSUS HCG TRIGGERING FOR INTRAUTERINE INSEMINATION: A RETROSPECTIVE ANALYSIS
    A. Vitagliano, A. Politi, S. Mosele, E. Riviello, B. Bellamio, F. Esposito, S. Borgato, L. Marin, A. Andrisani, G. Ambrosini.
    Università degli Studi di Padova, Padova, Italy.
  • P-28
    EFFECTS OF TESTOSTERONE ADMINISTRATION IN POOR RESPONDER PATIENTS UNDERGOING IVF
    S. Mosele1, A. Vitagliano1, F. Esposito1, E. Riviello1, B. Bellamio1, A. Politi2, S. Borgato2, L. Marin2, G. Ambrosini1, A. Andrisani1.
    1University of Padua, Padova, Clinica Ginecologica ed Ostetrica, PMA, Italy; 2University of Padua, Clinica Ginecologica di Padova, PMA, Italy.
  • P-29
    HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HPHMG) BEFORE DAY SEVEN IN A CORIFOLLITROPIN ALFA (CFA) STIMULATION PROTOCOL DOES NOT INCREASE THE NUMBER OF OOCYTES RETRIEVED.
    A. Salazar-Vera1, N. Garrido2, J.M. Vilar-Sánchez1, R. Quiroga-Gil1, A. Cejudo-Román1.
    1IVIRMA Málaga, Málaga, Spain; 2IVIRMA Foundation, Valencia, Spain.
  • P-30
    IS THE PREGNANCY RATE BETTER WITH SOME GONADOTROPIN IN LOW RESPONDERS REGARDLESS OF THE WOMAN'S AGE?
    K.M. Pavón Sáenz1, A. Lera Ramírez1, L. Gil Guillén1, A. Solé Mayoral1, D.C. Méndez Guevara1, A.M. Muñoz Ledesma1, M. García Yuste1, A.B. Rodriguez Bújez1, Y. Pascual Arévalo1, E. Mancha Heredero1, P.A. Merino García1, M. Santana Macías2, A. Álvarez González3, A.C. Acha Salazar1, J.M. Viteri Estévez1.
    1Hospital Universitario Río Hortega, Valladolid, Spain; 2Hospital Universitario de Guadalajara, Guadalajara, Spain; 3Hospital Rio Carrión, Palencia, Spain.
  • P-31
    THE EFFICACY OF LONG-ACTING HUMAN GROWTH HORMONE IN POOR RESPONDERS
    J.S. Mun1, K.Y. Moon2.
    1Gaya Womens Clinic, Jinju, Republic of South Korea; 2Maria Feritility Hospital, Pusan, Republic of South Korea.
  • P-32
    OVARIAN RESPONSE IN PATIENTS WITH BREAST CANCER AFTER CONTROLLED STIMULATION
    A. Vázquez Sarandeses, L. Marqueta Marques, M. Abad, C. Sanz, S. Aragon, L. De La Fuente Bitaine, M. Carrera Roig, N. Ruiz, P. Moreno Fernandez, E. Escalante.
    Hospital 12 de Octubre, Madrid, Spain.
  • P-33
    DUAL TRIGGER, AN EFFECTIVE SECOND LINE STRATEGY.
    M. Hernandez Ontoria, J. Sanz Pablos, L. Marqueta, M. Abad, M. Carrera, E. Escalante, P. Moreno, L. De La Fuente.
    Hospital 12 Octubre, Madrid, Spain.
  • P-34
    EVALUATION OF THE EFFICIENCY OF CONTROLLED OVARIAN STIMULATION BY FORT IN PATIENTS CLASSIFIED ACCORDING TO POSEIDON GROUP CRITERIA
    R. Garrido Casserres1, S. Vazquez Rodriguez1, J. Escrig Estrems1, N. Pellicer De Castellví1, M. Duarte Pérez1, J.M. Soler Torró2, R. Taroncher Dasí1, N. Blasco Ramos1, J.M. Rubio Rubio1.
    1Human Reproduction Unit, Hospital La Fe Valencia, Spain; 2Health Department Direction, La Ribera, Valencia, Spain.
  • P-35
    LIVE BIRTH RATES AFTER IMMEDIATE AND DELAYED ELECTIVE FROZEN EMBRYO TRANSFER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    C. Marques, S. Reis Soares, S. Santos-Ribeiro.
    IVIRMA, Lisboa, Portugal.
  • P-36
    THE IMPACT OF THE ECONOMIC RECESSION IN GREECE ON ASSISTED REPRODUCTION DEMAND
    K. Sfakianoudis1, M. Simopoulou2, A. Rapani3, S. Grigoriadis3, E. Maziotis3, P. Giannelou3, A. Pantou1, E. Deligeoroglou4, M. Koutsilieris3, K. Pantos1.
    1Centre for Human Reproduction, Genesis Athens Clinic, Athens, Greece; 2Department of Physiology - Department of Obstetrics and Gynaecology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 3Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 4Assisted Conception Unit, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • P-37
    MAMMALIAN DEVELOPMENTAL PLASTICITY AFTER EMBRYO VITRIFICATION-TRANSFER PROCEDURE IS PATENT AT ADULTHOOD
    X. Garcia-Dominguez, D. S Peñaranda, J. S Vicente, F. Marco-Jimenez.
    Universitat Politècnica de València, Valencia, Spain.
  • P-38
    KIDSCORE™ D5 ALGORITHM AS AN ADDITIONAL TOOL TO MORPHOLOGIC ASSESSMENT AND PGT-A FOR EMBRYO SELECTION: A TIME-LAPSE STUDY
    E. Gazzo1, F. Peña1, F. Valdez2, S. Sessarego3, A. Chung1, C. Bonomini1, M. Ascenzo1, M. Velit1, E. Escudero1.
    1Inmater Clinica de Fertilidad, Lima, Peru; 2Genomics Perú, Lima, Peru; 3Inmater Clinica de Fertilidad, Lima, Ecuador.
  • P-39
    BLASTOCYST CONTRACTIONS ARE STRONGLY RELATED WITH ANEUPLOIDY, LOWER IMPLANTATION RATES AND SLOWER EMBRYO CLEAVAGE TIMING: TIME LAPSE STUDY
    E. Gazzo1, F. Peña1, F. Valdez2, A. Chung1, M. Velit1, M. Ascenzo1, E. Escudero1.
    1Inmater Clinica de Fertilidad, Lima, Peru; 2Genomics Perú, Lima, Peru.
  • P-40
    METABOLITES PROFILING IN CULTURE MEDIUMS OF 5-DAY HUMAN EMBRYOS AS PREDICTORS OF SUCCESSFUL IMPLANTATION.
    V. Smolnikova1, I. Zorina1, M. Bobrov1, N. Makarova1, V. Zgoda2, E. Kalinina1.
    1Kulakovs Scientific Centre of Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation; 2Oxylipin Lab. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.
  • P-41
    USE OF OOCYTE MATURATION IN VITRO (IVM) FOR A NARROW GROUP OF PATIENTS
    M. Pavlova, E. Koloda, E. Volkomorova, A. Trofimova, N. Kornilov, E. Petrova, K. Chernoshtan, D. Valeeva.
    NGC, Saint-Petersburg, Russian Federation.
  • P-42
    CURRENT CRITERIA FOR OPTIMIZING INCUBATOR PARAMETERS
    M. Ortega-Llarena1, K.B. Ng2, N. Macklon3, Y. Cheong2.
    1VivoPlex Medical, Southampton, United Kingdom; 2University of Southampton Hospital, Princess Anne Hospital, Southampton, United Kingdom; 3London Women's Clinic, London, United Kingdom.
  • P-43
    DAY 7 EUPLOID BLASTOCYSTS HAVE REDUCED MORPHOLOGIC GRADES AS COMPARED WITH DAY 5 AND 6 BLASTOCYSTS BUT SATISFACTORY SUSTAINED IMPLANTATION
    A. Tiegs1, L. Sun2, S. Neal1, E. Osman1, J. Kim1, B. Hanson1, R. Scott1.
    1IVI-RMA, Basking Ridge, United States; 2Foundation for Embryonic Competence, Basking Ridge, United States.
  • P-44
    DO VARIATIONS EXIST IN FERTILIZATION, BLASTULATION, AND SUSTAINED IMPLANTATION RATES BY INTRACYTOPLASMIC SPERM INJECTION (ICSI) OPERATOR?
    A. Tiegs, B. Bauman, S. Neal, E. Osman, J. Kim, B. Hanson, R. Scott.
    IVI-RMA, Basking Ridge, United States.
  • P-45
    EXTRACELLULAR VESICLES CAN BE ISOLATED FROM CULTURE MEDIA WITH AND WITHOUT EXPOSURE TO HUMAN PREIMPLANTATION EMBRYOS
    D. Marin, E. Seli, R. Scott.
    IVIRMA New Jersey, Basking Ridge, United States.
  • P-46
    RELATIONSHIP BETWEEN THE INNER CELL MASS (ICM) OF BLASTOCYST WITH SUCCESS OF THE SINGLE EMBRYO-TRANSFER
    P. De Castro San Segundo, Y. Cabello, D. Ordoñez.
    Hospital Ruber Juan Bravo Quironsalud, Madrid, Spain.
  • P-47
    ENDOMETRIAL SCRATCH INJURY FOR WOMEN WITH ONE OR MORE PREVIOUS FAILED EMBRYO TRANSFERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    E. Riviello, A. Vitagliano, P. Angela, B. Beatrice, B. Shara, M. Stefania, L. Marin, F. Esposito, A. Guido, A. Andrisani.
    Università Degli Studi di Padova, Padova, Italy.
  • P-48
    ULTRASOUND-GUIDED EMBRYO TRANSFER (ET): SUMMARY OF THE EVIDENCE AND NEW PERSPECTIVES. A SYSTEMATIC REVIEW AND META-ANALYSIS
    A. Vitagliano, B. Bellamio, S. Mosele, A. Politi, E. Riviello, F. Esposito, S. Borgato, L. Marin, A. Andrisani, G. Ambrosini.
    University of Padua, SDB, Centro PMA, Padova, Italy.
  • P-49
    TRACTOCILE CAN IMPROVE PREGNANCY AND IMPLANTATION RATES IN FROZEN EMBRYO TRANSFERS OF PATIENTS WITH RECURRENT IMPLANTATION FAILURE AND HIGH NUMBER OF UTERINE CONTRACTIONS
    R. Leão, A. Schizzi Cambiaghi, A. Alvarez, P. Martins, P. Nascimento.
    IPGO, São Paulo, Brazil.
  • P-50
    RECIPIENTS OF DONOR OOCYTES HAVE SIMILAR OUTCOMES USING FRESH OR VITRIFIED OOCYTES IN AN EGG DONATION PROGRAM
    R. Leão, A. Schizzi Cambiaghi, A. Alvarez, P. Martins, P. Nascimento.
    IPGO, São Paulo, Brazil.
  • P-51
    TOTAL, MITOCHONDRIAL DNA (MTDNA) CONTENT DECREASES ALONG EMBRYO DEVELOPMENT, INSIGHTS OF MTDNA TURNOVER IN HUMAN PREIMPLANTATION DEVELOPMENT.
    M. Pérez-Sánchez1, M.F. Insúa1, A. Díez-Juan2, A. Mercader1, J. Bellver1, L. Escrich1, A. Pellicer1, M.J. De Los Santos1.
    1IVIRMA Global, Valencia, Spain; 2IGENOMIX, Valencia, Spain.
  • P-52
    INCREASE OF BLASTOCYST RATE WHEN ENVIRONMENT CONDITIONS ARE IMPROVED DURING HANDLING OF OOCYTES AND PRE-EMBRYOS IN AN IVF TREATMENT
    E. Santamaría-López, M. Ruíz, V. Blasco, M.J. Hernáez, P. Vime, M.D.L.Á. Valera-Cerdá, C. Caligara, J. Ramos, A. Tocino, N. Prados, M. Fernández-Sánchez.
    IVI RMA Seville, Seville, Spain.
  • P-53
    REMOVEMENT OF ANTIBIOTICS ALLOWS VIABLE BACTERIA SURVIVAL IN CRYOPRESERVED EMBRYOS AFTER LONG-TERM STORAGE
    X. Garcia-Dominguez1, L. Montoro-Dasi2, J.S. Vicente1, C. Marín2, F. Marco-Jiménez1.
    1Universitat Politècnica de València, Valencia, Spain; 2Universidad CEU-Cardenal Herrera, Alfara del Patriarca, Spain.
  • P-54
    CLINICAL EXPERIENCE ON GV-RESCUE. PART I: LABORATORY AND CLINICAL OUTCOMES
    A. Galán1, S. Pérez Albalá1, M.J. De Los Santos1, M.J. Escribá1, A. Pellicer2, L. Escrich1.
    1IVIRMA Valencia, Valencia, Spain; 2IVIRMA Roma, Roma, Italy.
  • P-55
    CLINICAL EXPERIENCE ON GV-RESCUE. PART II: DEFINING BENEFTED PATIENT PROFILE
    A. Galán, N. Grau, M.J. De Los Santos, M.J. Escribá, J. Remohí, L. Escrich.
    IVIRMA Valencia, Valencia, Spain.
  • P-56
    MITOCHONDRIAL DNA CONTENT OF CLEAVAGE STAGE EMBRYOS AND THEIR RELATION TO PREIMPLANTATION DEVELOPMENT AND ANEUPLOIDY
    A. Bayram1, N. Demunck1, I. Elkhatib1, A. Arnanz1, A. Linan2, B. Lawrenz1, H. Fatemi1.
    1IVIRMA Middle East Fertility Clinic, Abu Dhabi, United Arab Emirates; 2IVIRMA Middle East Fertility Clinic, Muscat, Oman.
  • P-57
    IMPROVEMENT OF ENDOMETRIAL RECEPTIVITY THROUGH THE USE OF AUTOLOGOUS PLATELET-DERIVED MICROPARTICLES
    E. Garijo Lopez, L. Garcia Bernardo, F. Galera Fernandez.
    Instituto Madrileño de Fertilidad (IMF), Madrid, Spain.
  • P-58
    IS THE PRESENCE OF A LYMPHOCITARY INFILTRATION IN THE SCRATCH INJURY BENEFICIAL IN THE RECURRENT IMPLANTATION FAILURE?
    L. Barrero Real1, E. García García1, L. Pérez Gallego2, M.A. Angel Miñarro3, V. Pascual Escudero4, J.A. Gobernado Tejedor1, L. Rodríguez-Tabernero Martín1, A.B. Casas Marcos1, E.M. Bayón Alvarez1, J.M. Molina Villar1, R. Velázquez Barbado1.
    1Hospital Clínico Universitario Valladolid, Unidad de Reproducción Humana Asistida Clínico Valladolid, Spain; 2Hospital Clínico Universitario Valladolid, Servicio de Anatomía Patológica, Spain; 3Facultad de Medicina, Facultad de Medicina, Spain; 4Hospital Clínico Universitario Valladolid, Servicio de Ginecología y Obstetricia, Spain.
  • P-59
    SPONTANEOUS PREGNANCY AFTER TREATMENT OF ASHERMAN SYNDROME.
    L. Asensio Romero, M.J. García Rubio, M. Valiente Cortés, B. Martín Cabrejas, G. Serrano Olmedo, J.M. Moreno Cebeira, C. Martín Caballero.
    Hospital Universitario Fundación de Alcorcón, Alcorcón, Spain.
  • P-60
    IS CHRONIC ENDOMETRITIS A POSSIBLE ETIOLOGY OF THE REPEATED IMPLANTATION FAILURE?
    E. García García1, L. Barrero Real1, L. Pérez Gallego1, M.Á. Ángel Miñarro2, V. Pascual Escudero1, J. Gobernado Tejedor1, L. Rodríguez Tabernero1, A.B. Casas Marcos1, E. Bayón Álvarez1, J.M. Fernández Gómez1, M.C. Del Pino Ortega1.
    1Hospital Clínico Universitario de Valladolid, Valladolid, Spain; 2Facultad de Medicina de Valladolid, Valladolid, Spain.
  • P-61
    RECTAL AND VAGINAL PROGESTERONE HORMONAL REPLACEMENT THERAPY (HRT) FOR FROZEN EMBRYO TRANSFER – A PROSPECTIVE COHORT STUDY
    B. Alsbjerg1, L. Thomsen2, H.O. Elbaek2, R. Laursen2, B.B. Povlsen2, T. Haahr2, P. Humaidan2.
    1Fertility Clinic, Skive Regional Hospital, Roslev, Denmark; 2Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
  • P-62
    OVARIAN STIMULATION IN PATIENT WITH PREMATURE OVARIAN INSUFFICIENCY
    L. Bonilla Garcia, B. Romero Guadix, M. Rios Lorenzo, J. Fontes Jimenez, L. Martinez Navarro.
    Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • P-63
    INVESTIGATING THE PROGNOSTIC VALUE OF AGE 35 AS A CUT-OFF POINT REGARDING DECISION MAKING IN IN VITRO FERTILIZATION TREATMENT: A RETROSPECTIVE DATA ANALYSIS
    M. Simopoulou1, K. Sfakianoudis2, S. Grigoriadis3, E. Maziotis4, P. Tsioulou3, A. Rapani4, P. Giannelou4, A. Pantou2, G. Mastorakos5, M. Koutsilieris4, K. Pantos2.
    1Department of Physiology - Department of Obstetrics and Gynaecology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 2Centre for Human Reproduction, Genesis Athens Clinic, Athens, Greece; 3Unit of Endocrinology, Diabetes Mellitus and Metabolism, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital and Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 4Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 5Unit of Endocrinology, Diabetes Mellitus and Metabolism, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • P-64
    GESTATION RATE IN WOMEN WITH LOW OVARIAN RESERVE AT PUBLIC HOSPITAL NOT RUNNING OOCYTE ACCUMULATION TECHNIQUES
    L. Gil Guillén, K.M. Pavón Sáenz, D.C. Méndez Guevara, A. Lera Ramírez, A. Solé Mayoral, M. García Yuste, A.M. Muñoz Ledesma, A.B. Rodríguez Bújez, E. Mancha Heredero, Y. Pascual Arévalo, M. Azpeitia Rodríguez, C.F. Montoya García, A. Álvarez González, A.C. Acha Salazar, J.M. Viteri Estévez.
    Hospital Universitario Río Hortega, Valladolid, Spain.
  • P-65
    NEW INSIGHT INTO THE ROLE OF MILD THYROID ABNORMALITIES IN RECURRENT PREGNANCY LOSS.
    N. Lazzarin1, E. Vaquero2, B. Valentini3, H. Valensise3.
    1Department Of Obstetrics and Gynaecology. Policlinico Casilino Hospital, Rome, Italy; 2*Department of Biomedicine and Prevention Obstetrics and Gynecological Clinic, University of Rome "Tor Vergata" Italy, Rome, Italy; 3Department of Obstetrics and Gynaecology, Policlinico Casilino Hospital, University of Rome “Tor Vergata” Italy., Rome, Italy.
  • P-66
    IS INSULIN RESISTANCE A CONTRIBUTING FACTOR TO RPL?
    E. Vaquero Martin1, N. Lazzarin2, B. Valentini3, H. Valensise3.
    1Department of Biomedicine and Prevention Obstetrics and Gynecological Clinic, University of Rome "Tor Vergata" Italy, Rome, Italy; 2Department of Obstetrics and Gynecology, Policlinico Casilino Hospital, Rome, Italy; 3Department of Obstetrics and Gynecology, Policlinico Casilino Hospital, University of Rome “Tor Vergata”, Rome, Italy.
  • P-67
    THE ROLE OF INTRAUTERINE ADMINISTRATION OF CRH-TREATED PBMC ON THE EXPRESSION OF CRH-R1 AND CRH-R2 RECEPTORS IN THE ENDOMETRIUM
    V. Dinopoulou, P. Drakakis, C. Theofanakis, D. Mavrogianni, K. Stefanidis, D. Loutradis.
    Division of Human Reproduction, IVF Unit, 1st Department of Obstetrics and Gynaecology Alexandra Hospital, University of Athens Medical School, Greece.
  • P-68
    IMPACT OF THYROID AUTOANTIBODIES AND THYROID FUNCTION ON CLINICAL IVF OUTCOME
    K.Y. Moon1, B.C. Jee2, S.H. Kim2.
    1Maria Fertility Hospital, Pusan, Republic of South Korea; 2Seoul National University College of Medicine, Seoul, Republic of South Korea.
  • P-69
    PILOT STUDY INVESTIGATING BASAL SERUM PROGESTERONE AS PROGNOSTIC CRITERION OF FROZEN THAWED EMBRYO TRANSFER OUTCOME WITH PGT-A
    D. Obidniak1, A. Gzgzyan2, A. Kalugina1, D. Niauri2.
    1"AVA Peter" Clinic, Saint-Petersburg, Russian Federation; 2Saint Petersburg State University, Medical Faculty, Saint-Petersburg, Russian Federation.
  • P-70
    CRYO-THAWED EMBRYO TRANSFER: ENDOMETRIUM PREPARATION AND FACTORS THAT INFLUENCE IN PREGNANCY RESULTS.
    D.C. Méndez Guevara, A. Solé Mayoral, A. Lera Ramirez, K.M. Pavón Sáez, L. Gil Guillén, A.C. Acha Salazar, J.M. Viteri Estévez, M. García Yuste, A.B. Rodríguez Bújez, A.M. Muñoz Ledesma, E. Mancha Heredero, Y. Pascual Arévalo.
    Hospital Universitario Rio Hortega, Valladolid, Spain.
  • P-71
    GESTATION AFTER TREATMENT OF MALE HYPOGONADOTROPIC HYPOGONADISM
    D. Sáez De La Mata, S. Sessa Mendez, A. Gaitero Martinez, M.V. Herranz Izquierdo, F.M. Ros Berruezo, J.M. Martinez De Maria.
    Hospital Sanitas La Moraleja, Alcobendas, Madrid, Spain.
  • P-72
    PREDICTIVE VALUE OF SERUM PROGESTERONE LEVEL ON DAY 4, DAY 7 AND DAY 11 AFTER BLASTOCYST TRANSFER IN A HORMONAL REPLACEMENT THERAPY CYCLE.
    E. Labarta, G. Mariani, E. Bosch.
    IVI RMA, Valencia, Spain.
  • P-73
    ASSOCIATIONS OF SEMEN QUALITY AND OXIDATION REDUCTION-POTENTIAL WITH CONCENTRATION OF CADMIUM, LEAD AND MERCURY IN SEMINAL PLASMA.
    A. Wdowiak1, A. Mroczkowski2, S. Bakalczuk2.
    1Medical University of Lublin, Lublin, Poland; 2Ovum RiA Lublin, Lublin, Poland.
  • P-74
    SPERM HEAD VACUOLE-LIKE STRUCTURES: IMPACT OF SEMEN MICROBIOME AND EXPOSURE TO ENVIRONMENTAL TOXICANTS.
    O. Gaspard1, C. Pirard2, L. Dewalque2, V. Gridelet1, C. Jouan1, P. Gavage3, F. Thonon1, S. Ravet1, F. Wenders1, S. Labied1, L. Henry1, C. Charlier2, S. Perrier D'hauterive1, M. Nisolle1.
    1Centre de Procréation Médicalement Assistée, CHU Liège, Belgium; 2Service de Toxicologie Clinique, CHU Liège, Belgium; 3Laboratoire de Biologie Clinique, CHR Liège, Belgium.
  • P-75
    THE IMMUNOMODULATION POTENTIAL OF SEMINAL PLASMA: IMPLICATION IN THE SUCCESS OF IVF TREATMENT
    V. Smolnikova, A. Babayan, M. Nikolaeva, E. Kalinina, L. Krechetova.
    National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russian Federation.
  • P-76
    OPTIMIZING THE PROTOCOL FOR VITRIFICATION OF INDIVIDUAL SPERMATOZOA BY ADJUSTING EQUILIBRATION TIME
    M. Belenky1, D. Itzhakov1, A. Berkovitz2.
    1MFC Male Fertility Center, Rishon LeZion, Israel; 2Assuta Medical Cemter, Rishon LeZion, Israel.
  • P-77
    SPERM KINETIC PATTERN WITH SHIFT FROM WHO 1999 TO WHO 2010 CRITERIA
    L. Veleva1, I. Bochev1, R. Petkova1, D. Duylgerova - Nikolova2, T. Milachich1.
    1Ob./Gyn. Hospital "Dr. Shterev", Sofia, Bulgaria; 2Medical Center "Reproductive Health", Sofia, Bulgaria.
  • P-78
    IS THE TELOMERE PATHWAY IMPLICATED IN MALE FERTILITY?. PRELIMINARY RESULTS.
    C. Balmori1, G. De Alba2, I. Sánchez De La Puerta2, A. Pacheco3, J.A. Garcia Velasco2, E. Varela2.
    1Rey Juan Carlos University, Madrid, Spain; 2IVIRMA, Madrid, Spain; 3Alfonso X El Sabio University, Madrid, Spain.
  • P-79
    MOLECULAR DIAGNOSIS OF RESISTANCE TO CRYOPRESERVATION IN SEMEN DONORS
    E. Sellés1, P. Hernández-Vargas1, N. Garrido2, F. Vilella3, I. Pérez1, M. Muñoz1.
    1IVIRMA, Alicante, Spain; 2IVI Foundation, Valencia, Spain; 3IGENOMIX, Valencia, Spain.
  • P-80
    EMBRYONIC ANEUPLOIDY RATES IN PATIENTS UTILIZING SURGICAL SPERM ARE EQUIVALENT TO THOSE UTILIZING EJACULATED SPERM FOR IN VITRO FERTILIZATION (IVF) CYCLES
    E. Osman1, S. Neal1, A. Tiegs1, J. Kim1, B. Hanson1, M. Werner1, L. Sun2, J. Franasiak1, R. Scott1.
    1IVI RMA, Basking Ridge, United States; 2Foundation for Embryonic Competence, Basking Ridge, United States.
  • P-81
    THE ‘REAL WORLD DATA’ ON USAGE OF FROZEN EGGS ON SOCIAL(ELECTIVE) PURPOSES IN KOREA: EXPERIENCE OF SINGLE PRIMARY CENTER
    C.W. Choo1, J. Park2, S.K. Kim3, W.D. Lee1, J.H. Lim1.
    1Seoul Maria Hospital, Seoul, Republic of South Korea; 2Sarang I Infertility Clinic, Seoul, Republic of South Korea; 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of South Korea.
  • P-82
    PRESERVATION OF FERTILITY BREAST CANCER VS OTHER CAUSES
    L. Bonilla Garcia, B. Romero Guadix, M. Rios Lorenzo, J. Mozas Moreno, J. Fontes Jimenez, R. Sanchez Ruiz, L. Martinez Navarro.
    Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • P-83
    LAPAROSCOPIC RADICAL TRACHELECTOMY FOR FERTLITY PRESERVATION IN CERVICAL CANCER
    S. Dobbs, I. Harley, E. Craig, H. Nagar, M. Mccomiskey.
    Belfast City Hospital, Belfast, United Kingdom.
  • P-84
    FERTILITY PRESERVATION PROGRAM FOR ONCOLOGIC PATIENTS IN OUR UNIT: 2 YEARS OF EXPERIENCE.
    V. Pascual Escudero, A.B. Casas Marcos, L. Barrero Real, E.M. Bayón Álvarez, E. García García, L. Rodriguez-Tabernero Martín, J.A. Gobernado Tejedor, A.I. Exposito Navarro, L. Barrigón Blanco.
    SACYL, Hospital Clínico Universitario de Valladolid, Spain.
  • P-85
    MMP-9 LEVELS AND ENDOMETRIOSIS FERTILITY INDEX IN INFERTILE WOMEN WITH ENDOMETRIOSIS
    A. Bostanc? Durmus1, S. Dincer Cengiz2, A. Yarci Gursoy2, T. Candar2, G.S. Caglar2.
    1Ankara Dr. Sami Ulus Obstetrics and Gynecology and Pediatrics Hospital, Ankara Dr. Sami Ulus Obstetrics and Gynecology and Pediatrics Hospital, Turkey; 2Ufuk University Faculty of Medicine, Ankara, Turkey.
  • P-86
    CASE REPORT: ETHANOL SCLEROTHERAPY FOR TREATING ENDOMETRIOMAS IN PATIENT WITH PRIMARY STERILITY
    V. Di Girolamo, B. Romero Guadix, L. Bonilla García, I. Zurimendi Gorrochategui, M. Ríos Lorenzo, R. Sánchez Ruiz, L. Martínez Navarro.
    Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • P-87
    MULTIPLE PREGNANCY AFTER IN VITRO FERTILIZATION IN A PATIENT WITH OVARIAN POLYCYSTIC SYNDROME, OVARIAN AND DEEP ENDOMETRIOSIS, ADENOMYOSIS AND UTERINE MYOMATOSIS
    C. Sanz Perez, S. Lobo, O. Armijo, S. Iniesta, P. Silva, M.J. Sanchez, S. Fernandez, M. Martin, A. Hernandez.
    Hospital La Paz, Madrid, Spain.
  • P-88
    WOMEN WITH ENDOMETRIOSIS HAVE WORSE RESUTLS IN IVF TECHNIQUES IN OUR CENTER?
    L. Bonilla Garcia, B. Romero Guadix, V. Di Girolamo, J. Fontes Jimenez, R. Sánchez Ruiz, L. Martínez Navarro.
    Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • P-89
    ENDOMETRIOSIS: SURGERY OR EXPECTANT HANDLING BEFORE ARTIFICIAL INSEMINATION
    L. Bonilla Garcia, B. Romero Guadix, I. Zurimendi Gorrotxategui, J. Mozas Moreno, L. Martinez Navarro.
    Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • P-90
    ENDOMETRIOMAS IN INFERTILE WOMAN: IS ETHANOL SCLEROTHERAPY A GOOD OPTION FOR TREATMENT?
    M. Rios Lorenzo, L. Bonilla Garcia, A.R. González Escudero, L. Martinez Navarro, B. Romero Guadix.
    Virgen de las Nieves University Hospital, Granada, Spain.

Palacio de Congresos de Palma de Mallorca

Calle Felicià Fuster, 2.
07006 Palma (Illes Balears)
IVI2019 | All rights Reserved.